Matches in SemOpenAlex for { <https://semopenalex.org/work/W2227246665> ?p ?o ?g. }
- W2227246665 abstract "Exercise interventions during adjuvant cancer treatment have been shown to increase functional capacity, relieve fatigue and distress and in one recent study, assist chemotherapy completion. These studies have been limited to breast, prostate or mixed cancer groups and it is not yet known if a similar intervention is even feasible among women diagnosed with ovarian cancer. Women undergoing treatment for ovarian cancer commonly have extensive pelvic surgery followed by high intensity chemotherapy. It is hypothesized that women with ovarian cancer may benefit most from a customised exercise intervention during chemotherapy treatment. This could reduce the number and severity of chemotherapy-related side-effects and optimize treatment adherence. Hence, the aim of the research was to assess feasibility and acceptability of a walking intervention in women with ovarian cancer whilst undergoing chemotherapy, as well as pre-post intervention changes in a range of physical and psychological outcomes. Newly diagnosed women with ovarian cancer were recruited from the Royal Brisbane and Women’s Hospital (RBWH), to participate in a walking program throughout chemotherapy. The study used a one group pre- post-intervention test design. Baseline (conducted following surgery but prior to the first or second chemotherapy cycles) and follow-up (conducted three weeks after the last chemotherapy dose was received) assessments were performed. To accommodate changes in side-effects associated with treatment, specific weekly walking targets with respect to frequency, intensity and duration, were individualised for each participant. To assess feasibility, adherence and compliance with prescribed walking sessions, withdrawals and adverse events were recorded. Physical and psychological outcomes assessed included functional capacity, body composition, anxiety and depression, symptoms experienced during treatment and quality of life. Chemotherapy completion data was also documented and self-reported program helpfulness was assessed using a questionnaire post intervention. Forty-two women were invited to participate. Nine women were recruited, all of whom completed the program. There were no adverse events associated with participating in the intervention and all women reported that the walking program was helpful during their neo-adjuvant or adjuvant chemotherapy treatment. Adherence and compliance to the walking prescription was high. On average, women achieved at least two of their three individual weekly prescription targets 83% of the time (range 42% to 94%). Positive changes were found in functional capacity and quality of life, in addition to reductions in the number and intensity of treatment-associated symptoms over the course of the intervention period. Functional capacity increased for all nine women from baseline to follow-up assessment, with improvements ranging from 10% to 51%. Quality of life improvements were also noted, especially in the physical well-being scale (baseline: median 18; follow-up: median 23). Treatment symptoms reduced in presence and severity, specifically, in constipation, pain and fatigue, post intervention. These positive yet preliminary results suggest that a walking intervention for women receiving chemotherapy for ovarian cancer is safe, feasible and acceptable. Importantly, women perceived the program to be helpful and rewarding, despite being conducted during a time typically associated with elevated distress and treatment symptoms that are often severe enough to alter or cease chemotherapy prescription." @default.
- W2227246665 created "2016-06-24" @default.
- W2227246665 creator A5009979971 @default.
- W2227246665 date "2010-01-01" @default.
- W2227246665 modified "2023-09-26" @default.
- W2227246665 title "An exercise intervention for women undergoing chemotherapy for ovarian cancer : feasibility and preliminary outcomes" @default.
- W2227246665 cites W1485580148 @default.
- W2227246665 cites W1515774339 @default.
- W2227246665 cites W1520778472 @default.
- W2227246665 cites W1553976553 @default.
- W2227246665 cites W1555037570 @default.
- W2227246665 cites W174733947 @default.
- W2227246665 cites W1752100969 @default.
- W2227246665 cites W1773129559 @default.
- W2227246665 cites W1857437878 @default.
- W2227246665 cites W1922469696 @default.
- W2227246665 cites W1964375677 @default.
- W2227246665 cites W1966733272 @default.
- W2227246665 cites W1972529513 @default.
- W2227246665 cites W1973812563 @default.
- W2227246665 cites W1974362328 @default.
- W2227246665 cites W1974668724 @default.
- W2227246665 cites W1976055328 @default.
- W2227246665 cites W1978927192 @default.
- W2227246665 cites W1980480266 @default.
- W2227246665 cites W1980882787 @default.
- W2227246665 cites W1981534943 @default.
- W2227246665 cites W1984790764 @default.
- W2227246665 cites W1987252323 @default.
- W2227246665 cites W1990805106 @default.
- W2227246665 cites W1994858221 @default.
- W2227246665 cites W1996568521 @default.
- W2227246665 cites W1996632091 @default.
- W2227246665 cites W1998617484 @default.
- W2227246665 cites W2005526202 @default.
- W2227246665 cites W2008869575 @default.
- W2227246665 cites W2009871531 @default.
- W2227246665 cites W2011014116 @default.
- W2227246665 cites W2011623694 @default.
- W2227246665 cites W2012773522 @default.
- W2227246665 cites W2013173007 @default.
- W2227246665 cites W2013338689 @default.
- W2227246665 cites W2016030234 @default.
- W2227246665 cites W2017391721 @default.
- W2227246665 cites W2018629609 @default.
- W2227246665 cites W2019970875 @default.
- W2227246665 cites W2020693031 @default.
- W2227246665 cites W2022352344 @default.
- W2227246665 cites W2022561481 @default.
- W2227246665 cites W2024831855 @default.
- W2227246665 cites W2026989196 @default.
- W2227246665 cites W2028353700 @default.
- W2227246665 cites W2028906348 @default.
- W2227246665 cites W2028946225 @default.
- W2227246665 cites W2035889265 @default.
- W2227246665 cites W2038393969 @default.
- W2227246665 cites W2039382931 @default.
- W2227246665 cites W2039406287 @default.
- W2227246665 cites W2039650731 @default.
- W2227246665 cites W2041737665 @default.
- W2227246665 cites W2041918383 @default.
- W2227246665 cites W2042665630 @default.
- W2227246665 cites W2045807085 @default.
- W2227246665 cites W2046782794 @default.
- W2227246665 cites W2048390374 @default.
- W2227246665 cites W2049458773 @default.
- W2227246665 cites W2049687555 @default.
- W2227246665 cites W2051843441 @default.
- W2227246665 cites W2058357469 @default.
- W2227246665 cites W2061892723 @default.
- W2227246665 cites W2063475706 @default.
- W2227246665 cites W2066028007 @default.
- W2227246665 cites W2066283884 @default.
- W2227246665 cites W2068912425 @default.
- W2227246665 cites W2071543758 @default.
- W2227246665 cites W2072639223 @default.
- W2227246665 cites W2075141829 @default.
- W2227246665 cites W2075479099 @default.
- W2227246665 cites W2075558320 @default.
- W2227246665 cites W2075734759 @default.
- W2227246665 cites W2076134069 @default.
- W2227246665 cites W2076668534 @default.
- W2227246665 cites W2078305255 @default.
- W2227246665 cites W2088337480 @default.
- W2227246665 cites W2088954277 @default.
- W2227246665 cites W2092841546 @default.
- W2227246665 cites W2092869153 @default.
- W2227246665 cites W2096574828 @default.
- W2227246665 cites W2097564109 @default.
- W2227246665 cites W2098463567 @default.
- W2227246665 cites W2099057931 @default.
- W2227246665 cites W2099521317 @default.
- W2227246665 cites W2100848202 @default.
- W2227246665 cites W2101077754 @default.
- W2227246665 cites W2104277553 @default.
- W2227246665 cites W2106572906 @default.
- W2227246665 cites W2106649306 @default.
- W2227246665 cites W2107519665 @default.
- W2227246665 cites W2107946734 @default.
- W2227246665 cites W2108881204 @default.